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This Month in the Journal
Mutations in a Novel Transmembrane Protein Cause
vLINCL, by Gao et al. (p. 324); and CLN6 Encodes a
Novel Predicted Transmembrane Protein (Report), by
Wheeler et al. (p. 537)
The neuronal ceroid lipofuscinoses (NCLs) are a group
of neurodegenerative disorders that are inherited in an
autosomal recessive manner and that are characterized
by progressive blindness, cognitive problems, and sei-
zures. One form of NCL is variant late-infantile neuronal
ceroid lipofuscinosis (vLINCL), which has symptom on-
set at 5–7 years of age and leads to death during the
mid 20s. The locus for vLINCL, CLN6, has been mapped
to chromosome 15q21-23. Gao et al. and Wheeler et al.
use samples of affected families to narrow the CLN6
locus and to identify a novel gene that is mutated in
these families. In the study by Gao et al., 13 Costa Rican
families share a haplotype, in the CLN6 region, that
includes a truncating mutation in exon 3 of the novel
gene; Wheeler et al. find the same mutation in 7 Costa
Rican families in their sample; and additional mutations,
including missense mutations, small insertions, and
small deletions, are identified in 9 additional families. A
spontaneous mutation in mice, nclf, causes NCL-like
disease and is identified, by both studies, as a single-base
insertion mutation in the mouse homolog of CLN6. The
mouse gene is highly identical to the human gene, and
homologs are also found in a variety of other species,
including chicken and Xenopus. The function of the en-
coded protein, dubbed “linclin” by Gao et al., is un-
known, because it does not have any obvious protein
relatives or functional domains. However, because mu-
tations in cln8 cause a phenotype in mice that is identical
to that seen in nclf mice, it is likely that linclin works
in the same functional pathway as does the protein en-
coded by cln8.
IL12 Deficiency, by Picard et al. (p. 336)
Familial cases of susceptibility to mycobacterial infection
have been described, and, although there is more than
one underlying genetic defect in these people, all result
in impaired interferon-g (IFNg)–mediated immunity. Af-
fected individuals are susceptible to bacille Calmette-
Gue´rin (BCG) vaccine, nontuberculous mycobacteria,
and Salmonella species. Mutations have been found in
the genes for IFNg receptor 1, IFNg receptor 2, the b1
chain of IL12R, signal transducer and activator of tran-
scription–1 (STAT1), and the p40 subunit of IL12, the
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last of which is encoded by IL12B and causes the only
known human inherited cytokine deficiency. Only one
person with IL12B deficiency has been described, and
that individual carried a large homozygous deletion in
IL12B. To find additional people with IL12 deficiency,
Picard et al. use IL12 production as a screen and identify
three patients, with a history of either BCG or nontu-
berculous myobacterial infections, who do not produce
detectable amounts of the IL12p40 subunit or of p70,
the full-sized heterodimer of IL12. One of these patients
has a deletion identical to the one found previously. The
other two, unrelated patients have the same one-base
insertion in IL12B, which leads to a premature stop
codon. Sequence analysis of additional affected families
identified two further kindreds with the same insertion
mutation. Not only are all of these individuals deficient
for IL12, but they also may be deficient for IL23, a
heterodimeric cytokine that is partially composed of the
p40 subunit of IL12. Further studies will help to dissect
the roles of these cytokines in immunity to mycobacteria.
Selection at the FY Locus, by Hamblin et al. (p. 369)
Because the major alleles of the Duffy blood group locus
(FY) have striking patterns of geographic differentiation,
FY is widely believed to be a target of natural selection.
A force for this selection is thought to be provided by
vivax malaria, because the FY*O allele confers resistance
to this parasite. Through examination of the patterns of
variation at FY—and comparison of these patterns to
those at neutral loci—Hamblin et al. find further support
for past selection at FY and evidence that there are pre-
viously unrecognized signatures of positive selection in
this region. A sample from sub-Saharan Africa, in which
the FY*O allele is fixed, shows evidence—based on two
independent measures, the level of sequence variation
and the frequency of nonancestral alleles—of directional
selection. The variation in this sample is consistent with
directional selection involving recombination. However,
in a Chinese sample, in which FY*A is nearly fixed, and
in an Italian sample, in which allele fixation has not
occurred, there are unusual patterns of variation, par-
ticularly in the region 3′ to FY. The departures from
neutrality in these samples do not fit a simple model of
directional selection, as do the African samples, but they
may represent a previously unrecognized signature of
positive selection in the FY region. The identity of this
selective force is unknown, because the function of the
Duffy antigen receptor is not fully understood.
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Gdnf and HSCR Haploinsufficiency, by Shen et al.
(p. 435)
Hirschsprung disease (HSCR) is a gastrointestinal (GI)
disorder with symptoms including vomiting, severe con-
stipation, and intestinal obstruction, and the main di-
agnostic criterion is the congenital absence of intrinsic
ganglion cells in the GI tract. Mutations in the genes for
endothelin 3 and its receptor, endothelin receptor type
B, have been associated with HSCR, as have mutations
in c-RET and its ligand GDNF. Mouse models have
given some insight into the disease mechanism for
HSCR, but they do not recapitulate the incomplete pen-
etrance and variable expressivity of HSCR symptoms
that are seen in affected people. Shen et al. identifyGdnf
haploinsufficiency in mice as a better model to represent
the expression of the HSCR-like phenotype. By crossing
Gdnf/ mice with strains that express b-galactosidase
in enteric ganglion cells, they were able to accurately
quantify the density of these cells along the GI tract in
each strain. Gdnf/ mice exhibit general hypogan-
glionosis that is more severe in the terminal gut and that
is present as early as embryonic day 10. Strain-dependent
differences in mortality associated with Gdnf/ sug-
gest that modifying loci play a role in the outcome of
Gdnf mutations. Although the functional impairment of
Gdnf/ mice is variable, hypoganglionosis is associ-
ated with gut dysmotility and appears to be a defect that
renders the mice susceptible to these HSCR-like symp-
toms. Therefore, the degree of hypoganglionosis in hu-
man HSCR may be an important determinant of the
disease phenotype, although it is not currently possible
to accurately assess the level of ganglion-cell density in
the human GI tract.
Detection of Errors in Nuclear-Family Data, by
Douglas et al. (p. 487)
In gene-mapping studies, inconsistencies with Mendelian
inheritance are often used as the only means of screening
for genotyping errors. Douglas et al. examine the ac-
curacy of this screening procedure, through calculations
of the expected probability of detecting a genotyping
error or mutation in nuclear-family data. These proba-
bilities are a function of the number of genotyped par-
ents and offspring and of the marker-allele frequency
distribution. Even under the best circumstances, a sub-
stantial fraction of genotyping errors are not detected
with analysis of Mendelian-inheritance inconsistencies;
these errors are especially difficult to detect when bial-
lelic markers are used. Douglas et al. suggest that ad-
ditional error-checking procedures, such as multipoint
analysis or partial duplicate genotyping, may be used to
ensure better error detection. Because both genotyping
errors and pedigree errors can result in inheritance in-
consistencies in nuclear families, distinguishing between
the two sources of error can be difficult, especially in
the early part of a study. The work of Douglas et al.
enables researchers to estimate the expected number of
inheritance inconsistencies. If any families in a study ex-
ceed the expected number, then pedigree error, rather
than genotyping error, is the likely culprit, and these
cases can be dealt with appropriately.
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